Home BioMark Diagnostics

BioMark Diagnostics

In operation
Post-IPO Round
Early Cancer Diagnosis Technology Developer
Basic
Enterprise Profile

Basic Information

Biomark Diagnostics Inc. is a Canadian-based oncology company. It is engaged in the development of an early cancer diagnostic technology platform. The non-invasive cancer diagnostic solutions developed by the company will help in the detection, monitoring, and evaluation of early cancer treatment. Its research and development focuses on the role of metabolomics in early cancer detection. It is currently concentrating on commercializing its liquid biopsy-based cancer diagnostic tests and detection solutions.
Biomark Diagnostics Inc.
BritishColumbia,Canada
15~50 people
January 01, 2006
info@biomarkdiagnostics.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design
Technology
Liquid Biopsy
Concept
Laboratory Diagnosis Ovarian Cancer Pancreatic Cancer
Application Scenarios
Medical Device Consumables Early Disease Screening